Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23398,100,2.59 [1.61-4.18],8.88140190225208e-05
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24030,181,1.83 [1.26-2.65],0.0015909738923777
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23799,1158,1.62 [1.38-1.90],4.878012355098797e-09
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Candidiasis,24061,407,1.73 [1.34-2.23],2.0251322246467483e-05
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23312,3043,1.50 [1.35-1.67],6.306318033726316e-14
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23515,2472,1.48 [1.31-1.66],1.7509963955957308e-10
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23808,1170,1.36 [1.15-1.61],0.0004203674249766
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23959,80,1.76 [1.01-3.08],0.0474960461639001
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22469,697,2.14 [1.77-2.59],3.305035014463274e-15
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21706,796,2.27 [1.87-2.75],1.7789005516409624e-16
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21762,217,2.21 [1.57-3.12],5.316521988688837e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16880,1430,1.53 [1.31-1.79],9.823426286857729e-08
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21567,318,2.06 [1.52-2.78],2.6206379544361603e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23998,1360,1.43 [1.22-1.66],7.185269877924734e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Mycoses,24114,460,1.70 [1.34-2.16],1.4639282024914029e-05
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23462,821,1.72 [1.43-2.08],1.3448979769772505e-08
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24065,767,2.08 [1.73-2.49],5.487673957558435e-15
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22819,181,1.84 [1.28-2.66],0.0011390389963164
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24170,39,1.51 [0.62-3.64],0.3627592947062835
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23975,677,2.18 [1.80-2.63],5.029941784081155e-16
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23955,76,1.96 [1.10-3.47],0.0216775776054939
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24085,168,1.40 [0.91-2.16],0.1239917457654837
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24070,153,1.34 [0.85-2.13],0.2068216694682433
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22936,295,1.94 [1.47-2.56],2.497472680411916e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22866,225,1.54 [1.08-2.21],0.0174589422090825
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22737,99,1.84 [1.11-3.07],0.0190104604018679
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24147,35,2.31 [1.32-4.05],0.0033541435477201
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24102,141,1.01 [0.60-1.70],0.9610782761775548
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral warts,24002,41,0.77 [0.29-2.07],0.6089989621174867
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24031,70,1.11 [0.54-2.29],0.7842728838799682
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm,23927,208,1.09 [0.71-1.66],0.7005187675442757
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24077,61,1.32 [0.63-2.76],0.457515906808616
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24070,59,1.51 [0.75-3.04],0.2495897382316591
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23914,1055,1.06 [0.87-1.28],0.5655444636642359
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of meninges,24145,75,1.17 [0.58-2.37],0.6570838895242743
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24111,61,0.88 [0.39-1.97],0.7518750342591565
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24139,116,0.74 [0.41-1.34],0.3211647602049772
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of ovary,24100,150,1.03 [0.63-1.70],0.9013760694840252
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24150,237,0.79 [0.52-1.19],0.2614038804721811
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Caecum,24156,215,1.10 [0.73-1.68],0.6429520153016417
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24089,58,1.77 [0.88-3.55],0.1105617438077363
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Descending colon,24154,132,1.05 [0.61-1.78],0.8703516124694851
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Rectum,24117,242,1.10 [0.74-1.63],0.6279573722655019
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24070,439,1.11 [0.83-1.49],0.4737012997074906
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24155,248,1.04 [0.70-1.54],0.8393862568026937
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Carcinoma in situ of breast,19562,122,1.48 [0.89-2.47],0.1319304824664521
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19633,140,1.35 [0.82-2.22],0.231080110852306
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19628,31,4.09 [2.42-6.91],1.3125578594664644e-07
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19654,57,2.48 [1.39-4.41],0.0020742411360435
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24108,126,1.60 [1.00-2.58],0.0516935357414672
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma, any site",24109,124,1.61 [1.00-2.59],0.0492879163705171
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Leiomyoma of uterus,23285,505,0.89 [0.68-1.17],0.4170536040715669
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Lung cancer and mesothelioma,17363,282,1.47 [0.99-2.17],0.0563727298610027
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Lymphoid leukaemia,19632,35,3.28 [1.96-5.48],5.643133915147588e-06
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19753,156,0.98 [0.59-1.61],0.9242141678734164
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19693,96,1.08 [0.58-2.03],0.8071894224322476
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19765,168,1.81 [1.19-2.74],0.0055482262674635
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19658,61,1.68 [0.82-3.43],0.1555812187270028
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19656,59,2.16 [1.28-3.63],0.0038578317113166
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19644,47,2.27 [1.23-4.20],0.0087093797972146
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19727,130,1.53 [0.94-2.51],0.0869834958043074
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19689,92,0.87 [0.45-1.68],0.6766179432972993
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19672,75,0.85 [0.41-1.76],0.6552093052900374
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19633,36,1.97 [0.85-4.56],0.1125730310824185
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19668,71,0.79 [0.37-1.68],0.5335481595896358
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi,23936,209,1.22 [0.81-1.83],0.338892501331495
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi of trunk,24129,70,1.02 [0.49-2.13],0.967021911912162
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanoma in situ,19626,77,0.93 [0.45-1.92],0.8434846506297121
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19669,72,2.83 [1.84-4.36],2.319090117202684e-06
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19732,135,2.87 [2.16-3.82],3.4726200084255577e-13
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19803,206,1.44 [0.98-2.14],0.0657947441698542
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19681,84,2.93 [2.09-4.11],4.714479324670503e-10
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Other benign neoplasms of skin,23971,156,0.68 [0.41-1.13],0.1327248546612181
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20412,815,0.93 [0.75-1.16],0.5217449556297752
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20448,851,0.94 [0.76-1.17],0.6027579498451334
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23886,340,2.08 [1.66-2.61],2.1123814118823823e-10
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22427,85,3.00 [1.86-4.82],5.946045306021445e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23616,70,1.51 [0.80-2.86],0.2058437946923496
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23276,2582,1.46 [1.30-1.64],1.4627943640165866e-10
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22755,27,0.97 [0.28-3.30],0.9607869708604438
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23818,43,2.97 [1.74-5.08],7.075748076364648e-05
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23654,1312,1.51 [1.28-1.77],5.099857119490726e-07
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23654,1312,1.51 [1.28-1.77],5.099857119490726e-07
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22409,67,2.51 [1.43-4.42],0.0013591203530948
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23807,1079,1.63 [1.38-1.92],5.9642709049929184e-09
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23878,103,1.83 [1.13-2.96],0.0148123653740537
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23592,46,2.00 [1.01-3.96],0.04600167874822
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23600,54,1.17 [0.52-2.63],0.6988173681492794
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23982,207,2.29 [1.72-3.05],1.6745387273553896e-08
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24075,54,2.35 [1.34-4.11],0.002733092049011
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23951,176,2.31 [1.71-3.11],3.5253487273059994e-08
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22842,114,0.83 [0.46-1.51],0.5460255780605663
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19503,211,1.68 [1.12-2.51],0.0117074162963075
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22918,59,0.33 [0.15-0.75],0.0080766835167626
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22914,55,0.76 [0.33-1.76],0.5208976615050609
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,19335,43,1.85 [0.78-4.39],0.1621642149185162
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22167,54,1.81 [0.88-3.73],0.1083504355343736
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21887,209,1.05 [0.69-1.61],0.8114928273690045
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23783,423,1.18 [0.87-1.59],0.2920220992680182
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23624,264,0.85 [0.57-1.26],0.4112403234426031
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23421,61,1.40 [0.65-3.03],0.3931332004276926
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23830,1717,1.07 [0.92-1.24],0.36506586444903
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21437,1679,1.06 [0.92-1.24],0.4207016621716604
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",19339,47,1.88 [0.84-4.18],0.1239624362289468
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21495,103,1.52 [0.86-2.69],0.1496382687550571
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19539,247,0.97 [0.65-1.45],0.878917036485425
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,19335,43,1.63 [0.68-3.90],0.2701692775064547
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22040,2748,1.28 [1.14-1.44],3.564369097571453e-05
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19477,185,1.84 [1.21-2.79],0.0040939965823124
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19769,477,1.34 [1.01-1.77],0.0409330377855985
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24084,314,0.76 [0.53-1.09],0.1309574388365436
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23916,146,0.63 [0.37-1.07],0.087775311497966
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19381,89,0.75 [0.38-1.48],0.4085596195777522
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",19342,50,3.82 [2.35-6.21],6.581199442717008e-08
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23399,2007,1.26 [1.10-1.44],0.0007897993718531
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19469,177,2.69 [1.87-3.86],9.493231343466289e-08
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19466,174,2.19 [1.44-3.34],0.0002451460521745
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19760,468,1.24 [0.93-1.65],0.1355827140943557
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19363,71,1.62 [0.80-3.31],0.1828325990327809
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23910,140,0.60 [0.35-1.04],0.067992752669108
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19828,536,1.85 [1.45-2.36],7.831298427650162e-07
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19778,486,1.61 [1.24-2.11],0.0004189719634186
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21742,64,1.74 [0.94-3.24],0.0804004626068251
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23397,4105,1.34 [1.22-1.47],1.2391716296154415e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21456,64,1.32 [0.63-2.78],0.4656068059438831
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21468,76,0.98 [0.48-2.02],0.9644646744635498
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24005,1797,0.96 [0.83-1.11],0.5416452625965666
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24009,1796,0.96 [0.83-1.11],0.5636394103811115
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21466,74,1.21 [0.60-2.46],0.5960393560198208
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23806,1383,1.00 [0.85-1.18],0.9781470752303136
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20598,1306,1.72 [1.47-2.02],3.0847203919080685e-11
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24160,160,1.33 [0.83-2.13],0.2288570387817922
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23402,42,1.97 [0.87-4.50],0.1058892386408895
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22544,121,1.19 [0.68-2.06],0.5445340988391192
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22594,171,1.09 [0.68-1.75],0.7334793854352333
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19512,220,1.82 [1.24-2.67],0.0020874597232324
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22566,122,1.62 [0.98-2.69],0.0600660179420993
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1497,38,0.90 [0.34-2.43],0.8375173115339546
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1592,150,1.19 [0.73-1.95],0.4833226807227594
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22469,25,2.58 [1.04-6.36],0.0398931927694573
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1480,22,1.02 [0.28-3.71],0.970676783090364
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23753,1309,1.67 [1.43-1.94],4.54676934216208e-11
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23656,296,0.91 [0.63-1.32],0.6188640820463343
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22098,420,1.36 [1.03-1.80],0.0318892798839112
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19914,622,1.51 [1.19-1.92],0.0007430670974889
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24081,206,1.25 [0.83-1.90],0.2849848288346924
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23269,44,1.14 [0.45-2.87],0.7779295244799692
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Angina pectoris,22831,761,1.21 [0.97-1.51],0.0959246493034732
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23305,80,1.47 [0.78-2.78],0.2384236900132611
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23254,29,1.00 [0.31-3.23],0.9975665305645306
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23364,139,1.75 [1.11-2.77],0.0159636772306867
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15700,1270,1.45 [1.22-1.73],1.985295735280494e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,AV-block,21204,213,1.15 [0.75-1.76],0.5283539158404661
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24128,264,1.21 [0.84-1.75],0.3062297333969982
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiac arrest,14539,109,1.43 [0.80-2.55],0.2219508895261874
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21111,120,1.06 [0.60-1.86],0.8430007479949488
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21064,73,1.27 [0.64-2.51],0.4989370221737751
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24166,28,0.45 [0.13-1.54],0.2043092914175494
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Conduction disorders,21628,637,1.55 [1.23-1.95],0.0001715529418414
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23369,1310,1.35 [1.14-1.59],0.0003702611002611
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21757,6411,1.24 [1.15-1.34],2.887590505430344e-08
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22855,219,1.33 [0.90-1.99],0.1569159427599984
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Endocarditis,21038,47,2.96 [1.83-4.77],8.996927626910103e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24082,731,1.96 [1.61-2.37],6.8521173242021174e-12
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertension,22306,5398,1.21 [1.11-1.32],7.941669631210181e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22314,5406,1.21 [1.11-1.31],9.793545175257253e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24069,35,1.61 [1.14-2.30],0.0076972211574771
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",17061,153,2.34 [1.61-3.39],8.307373547210488e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16976,68,2.59 [1.52-4.42],0.0004644286143885
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypotension,24050,928,1.30 [1.07-1.59],0.0085346859195885
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23508,85,0.91 [0.46-1.83],0.7946410046011788
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23552,1482,1.27 [1.09-1.49],0.002833701642884
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23894,398,1.07 [0.78-1.46],0.6750229301210969
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21261,270,1.55 [1.09-2.19],0.0144022201839691
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23979,532,1.26 [0.97-1.63],0.0860763452217196
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22495,425,1.35 [1.01-1.80],0.0442541446818446
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24146,78,0.82 [0.40-1.69],0.5933011184745705
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24162,211,1.43 [0.96-2.13],0.077151737401577
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Oesophageal varices,22670,34,4.44 [2.86-6.88],2.5648523347345958e-11
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other aneurysm,23275,50,0.99 [0.41-2.35],0.9742643620228456
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other arrhythmias,21313,322,1.14 [0.81-1.61],0.4485964976093288
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23285,60,1.04 [0.47-2.32],0.920025892945086
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23399,174,1.70 [1.14-2.52],0.0092290974221338
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21138,147,1.31 [0.81-2.11],0.2716829522408582
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other disorders of veins,22712,76,1.22 [0.61-2.41],0.5759678065181058
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22678,42,1.77 [0.87-3.60],0.1130866670746621
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23076,32,1.21 [0.41-3.52],0.7311349703843768
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22774,138,1.84 [1.18-2.87],0.0070325143698426
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21670,679,1.75 [1.42-2.16],1.207125788198908e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23160,38,3.25 [1.98-5.34],3.112368440645097e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23674,449,1.45 [1.11-1.89],0.0059381648097543
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23654,288,1.91 [1.41-2.58],3.114383982267125e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23513,469,1.04 [0.78-1.38],0.8107251736228593
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14681,251,1.71 [1.22-2.41],0.0019521310410199
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23460,246,1.36 [0.93-1.98],0.1083164185305357
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22924,288,1.31 [0.93-1.86],0.1247071424521512
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23756,390,1.46 [1.09-1.97],0.0113208449516626
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24097,504,1.86 [1.46-2.35],3.047719994244356e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21176,185,2.32 [1.66-3.24],9.069021946026404e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23647,281,1.96 [1.45-2.66],1.3670119148668982e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23179,135,2.05 [1.36-3.11],0.0006510046429767
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23885,462,1.04 [0.78-1.39],0.7867957003177499
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23861,503,1.06 [0.80-1.40],0.6933113675857254
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23477,62,1.08 [0.50-2.36],0.8378112748220182
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23262,37,1.73 [0.72-4.13],0.2193312502169093
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23682,186,0.94 [0.59-1.49],0.7910200065417495
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23625,178,1.12 [0.71-1.77],0.6273699497013316
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Varicose veins,23019,383,1.55 [1.16-2.07],0.0031684533435435
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23234,83,1.61 [0.90-2.88],0.1076551138050024
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23981,615,1.39 [1.10-1.77],0.0058144381169836
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24131,196,0.75 [0.48-1.18],0.2157951295374894
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21483,1617,1.01 [0.87-1.18],0.8917626359717824
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Any mental disorder,23644,3778,1.06 [0.96-1.17],0.2719643657748694
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24105,232,0.72 [0.48-1.09],0.124780007380863
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21601,1735,1.09 [0.94-1.27],0.2413950975018854
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19945,79,1.02 [0.50-2.06],0.9587681518488969
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Smoking dependency,23817,1043,1.11 [0.93-1.34],0.2554895415294729
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21076,1210,1.04 [0.87-1.25],0.6381581785287961
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Vascular dementia,23739,93,1.22 [0.64-2.33],0.5523029893735754
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Alzheimer disease,24168,327,0.86 [0.61-1.23],0.4104017489880717
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16568,53,1.06 [0.44-2.55],0.9042570952750172
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Bell's palsy,22288,71,1.66 [0.89-3.09],0.1085847545197387
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22779,562,0.76 [0.59-1.00],0.0477246925873844
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Cerebral cysts,23817,190,1.67 [1.16-2.39],0.0055905031752703
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24103,237,1.29 [0.88-1.91],0.191149452918281
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23742,39,1.68 [0.70-4.04],0.2431955287448272
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24157,44,1.77 [0.81-3.85],0.1517404673567615
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23672,45,2.23 [1.14-4.37],0.0189243230309451
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Epilepsy,22886,249,1.09 [0.74-1.62],0.6648048657543741
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23800,1163,1.03 [0.86-1.24],0.7151577034432471
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24124,310,1.08 [0.76-1.54],0.6669857568055618
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23624,2541,1.08 [0.95-1.22],0.2250685396481534
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Generalized epilepsy,23847,42,2.17 [0.99-4.78],0.0537399295925114
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Hemiplegia,24055,189,1.57 [1.05-2.36],0.0292073251649951
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Hydrocephalus,23682,55,0.79 [0.34-1.87],0.5942638867936478
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24150,65,1.32 [0.64-2.71],0.4573608189715129
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22330,113,1.18 [0.67-2.07],0.5651122500408646
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22272,55,0.76 [0.33-1.78],0.5287537301432844
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Memory loss,23625,93,0.99 [0.51-1.89],0.9637016768443516
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Migraine,23085,448,1.19 [0.89-1.58],0.2376040641567322
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24066,406,1.23 [0.92-1.64],0.1675533224182703
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Motor neuron disease,16657,117,0.67 [0.37-1.23],0.1943556284339258
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23965,124,0.76 [0.43-1.33],0.3351038560933033
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23439,1222,0.93 [0.78-1.11],0.4298187170664045
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Neurological diseases,22746,3250,0.98 [0.88-1.09],0.6936172508913628
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23828,125,1.52 [0.90-2.56],0.1186184314968463
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22586,369,0.73 [0.53-1.02],0.0621145903580286
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24115,196,1.92 [1.33-2.79],0.0005691227668059
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19558,583,0.94 [0.72-1.22],0.6328846240555208
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23686,59,1.20 [0.56-2.60],0.6390795024655084
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23737,110,0.57 [0.31-1.04],0.065345833470664
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23958,144,1.11 [0.67-1.86],0.6823838754845418
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22296,79,1.65 [0.92-2.95],0.0938497305765166
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other headache syndromes,22705,68,1.36 [0.66-2.81],0.3974822180541191
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other neurological diseases,24065,438,1.12 [0.84-1.49],0.4378779952881978
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other sleep disorders,22985,348,0.91 [0.65-1.28],0.5971999160663795
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Parkinson's disease,24145,145,1.04 [0.62-1.75],0.8912251282327264
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23699,72,1.28 [0.66-2.47],0.4642859560501985
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Restless leg syndrome,24167,77,0.81 [0.39-1.65],0.557246304577243
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Sleep apnoea,24013,278,0.97 [0.67-1.40],0.8679201774050894
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23953,34,3.23 [1.89-5.53],1.8551330177269124e-05
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24158,142,0.72 [0.42-1.23],0.2253185146835357
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22279,62,1.22 [0.57-2.64],0.6070541037978026
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24168,330,0.85 [0.60-1.21],0.3736342735557472
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23698,90,1.17 [0.60-2.28],0.6364520999056822
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23650,94,1.20 [0.64-2.25],0.5794313063757058
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23760,427,1.29 [0.97-1.74],0.0848765274798351
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24042,143,1.39 [0.85-2.29],0.1896110078915239
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23189,53,0.40 [0.17-0.98],0.0441774281212247
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23185,49,0.82 [0.33-2.02],0.6698265590594352
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24058,57,2.39 [1.35-4.25],0.0028630785052768
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23918,148,0.76 [0.45-1.29],0.3095073349529595
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1486,27,1.14 [0.36-3.62],0.8235884112232857
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1780,55,0.83 [0.36-1.92],0.6673951032755538
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23641,85,1.01 [0.52-1.98],0.9773401198138272
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24015,925,1.23 [1.00-1.50],0.0451689009455121
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23789,653,1.29 [1.02-1.63],0.0328550666057523
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23399,263,1.28 [0.88-1.86],0.1945649022090856
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24092,759,1.35 [1.09-1.68],0.0057062259962735
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24156,64,0.91 [0.42-2.00],0.8229427180591045
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24023,690,1.35 [1.07-1.69],0.0101271973744943
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24129,359,1.06 [0.76-1.47],0.7299324272743696
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24083,185,1.60 [1.06-2.41],0.0257088322243812
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23173,37,0.92 [0.33-2.60],0.8796219257594574
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23176,40,0.77 [0.28-2.15],0.6219098353983594
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23197,61,0.74 [0.33-1.68],0.4690063488178239
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24088,630,1.07 [0.84-1.37],0.5808777176631916
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23613,155,0.96 [0.58-1.59],0.8604049948688378
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23391,58,1.17 [0.52-2.64],0.6987385312287525
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23859,89,1.48 [0.80-2.73],0.2125231825942786
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24049,279,0.93 [0.64-1.36],0.7082809093295908
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23520,187,1.57 [1.06-2.33],0.0237298302671104
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24018,120,1.71 [1.04-2.81],0.035170278032311
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23867,409,1.30 [0.97-1.76],0.0817445232603621
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23693,137,0.91 [0.53-1.55],0.7171236091338464
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22585,2239,1.05 [0.92-1.20],0.4830171077635906
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24015,245,0.88 [0.59-1.32],0.5354681685148313
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24146,141,0.92 [0.54-1.56],0.7630261521699561
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23471,335,1.29 [0.93-1.79],0.1329136226874344
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23829,59,0.98 [0.43-2.23],0.967837886201092
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24142,50,0.72 [0.29-1.76],0.4669780032990311
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23220,84,1.02 [0.51-2.01],0.9646906983506832
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23263,127,1.13 [0.66-1.95],0.6584775306505228
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23184,94,1.00 [0.52-1.92],0.9909852878580968
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23392,59,1.62 [0.85-3.08],0.143596646083454
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23148,58,1.01 [0.45-2.29],0.9819265905578078
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23564,106,0.89 [0.48-1.64],0.7004187996484912
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23617,159,1.00 [0.61-1.65],0.9923856864477902
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23248,112,1.80 [1.08-3.00],0.0229491810204018
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23171,81,1.46 [0.78-2.74],0.2333867776100927
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23151,61,1.14 [0.51-2.53],0.7548901676958918
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22186,1840,1.19 [1.03-1.38],0.0175779443820934
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23215,79,1.30 [0.66-2.55],0.4519743070144936
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23937,381,1.01 [0.74-1.39],0.9445946634341438
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23597,41,1.66 [0.69-3.98],0.253434516675823
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23705,149,1.38 [0.85-2.23],0.193625312844643
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23942,102,0.81 [0.43-1.53],0.5212619304706643
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24126,95,0.82 [0.43-1.58],0.5608189798356955
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24059,129,0.96 [0.56-1.64],0.8706265644949418
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23904,64,1.82 [0.92-3.62],0.085630092776381
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23907,67,0.72 [0.33-1.56],0.4034965061116152
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24073,711,1.01 [0.80-1.28],0.9279772415207028
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23849,487,1.11 [0.84-1.47],0.469276893804008
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23464,102,0.70 [0.37-1.31],0.2643728022599942
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23438,76,0.83 [0.40-1.70],0.6113443282929563
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute pharyngitis,23920,75,0.90 [0.44-1.85],0.783661064765682
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24056,211,1.15 [0.77-1.74],0.4911736163195362
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23902,57,1.37 [0.68-2.77],0.3738457479957392
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,All influenza,22682,114,2.71 [1.74-4.21],9.587425837395595e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22681,113,2.75 [1.77-4.27],6.210544342346759e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17195,114,0.69 [0.38-1.25],0.2217983830723387
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Allergic rhinitis,24043,247,0.76 [0.51-1.14],0.1793724828762526
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18764,1844,1.11 [0.96-1.28],0.1690744646693553
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18900,1819,1.10 [0.95-1.28],0.1906217599979413
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23807,114,1.87 [1.23-2.85],0.0036720729439414
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22628,60,2.03 [1.00-4.11],0.049726372865196
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Bronchiectasis,20876,348,1.88 [1.44-2.47],3.983046382798139e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20587,59,0.80 [0.35-1.84],0.600714557293279
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23153,2625,1.14 [1.01-1.28],0.0342888500542298
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23048,59,0.97 [0.43-2.19],0.9321496911742664
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic sinusitis,23118,129,1.09 [0.63-1.87],0.7580535668772987
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24017,908,1.10 [0.90-1.35],0.3345427756572398
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Deviated nasal septum,23056,67,0.52 [0.24-1.15],0.1086847901240091
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22327,4530,1.24 [1.13-1.35],4.186845739670804e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23285,296,0.93 [0.65-1.33],0.6787628098322185
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Early onset COPD,23392,283,1.33 [1.02-1.73],0.0377988427557646
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Emphysema,20761,233,1.47 [1.07-2.03],0.0185525078477178
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22685,203,1.16 [0.76-1.78],0.4907741177097542
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23992,1424,1.86 [1.61-2.15],1.7161791019061924e-17
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Interstitial lung disease,22720,238,1.37 [0.94-2.00],0.1047153017160724
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Later onset COPD,23354,625,0.98 [0.77-1.26],0.8947132118752054
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24162,193,1.37 [0.89-2.10],0.1492551224842522
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Nasal polyp,23047,58,0.72 [0.31-1.66],0.4452972400252317
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23967,819,1.51 [1.24-1.84],4.345017046034106e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of pleura,24003,1534,1.65 [1.44-1.89],5.89233077465949e-13
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23677,688,0.89 [0.70-1.13],0.3336681233519362
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other pleural conditions,22504,35,2.83 [1.84-4.37],2.516829354349007e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24093,302,1.81 [1.32-2.46],0.0001903089716069
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24089,1040,1.51 [1.27-1.80],2.2758948367731103e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural effusion,23199,730,1.98 [1.66-2.36],2.6386871627869765e-14
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural plaque,22512,43,1.81 [0.85-3.86],0.1248813551180322
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23777,1209,1.84 [1.57-2.15],2.0319297439928724e-14
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24135,166,1.40 [0.89-2.21],0.1502092888707417
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pneumothorax,22558,89,1.76 [1.07-2.89],0.0251568147078747
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pollen allergy,24144,208,0.93 [0.61-1.43],0.7436260468891953
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pulmonary oedema,23845,54,3.15 [1.96-5.07],2.111514309275634e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17125,44,1.00 [0.39-2.53],0.9969309138587672
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23948,800,1.50 [1.23-1.84],6.933780655281299e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23236,247,0.76 [0.51-1.14],0.1802346612961527
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Viral pneumonia,22752,184,1.70 [1.11-2.59],0.0139589441545218
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23815,145,1.52 [0.96-2.41],0.0751565315550974
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11637,90,1.29 [0.67-2.49],0.454344250657642
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,17306,35,1.61 [0.69-3.76],0.2680927536676263
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute appendicitis,24001,123,0.97 [0.55-1.70],0.9151055993250172
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute gastritis,18166,75,0.87 [0.42-1.81],0.7114501505773532
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute pancreatitis,22162,143,1.51 [0.94-2.40],0.0864971372129707
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute peritonitis,23662,75,1.77 [1.03-3.03],0.0374630223030738
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23413,31,1.85 [1.00-3.43],0.049109308198186
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Barrett oesophagus,18398,307,1.21 [0.85-1.71],0.288122669276538
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22089,70,2.53 [1.53-4.20],0.000314992245899
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23796,70,2.52 [1.51-4.22],0.0004232822503145
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholecystitis,22174,155,1.07 [0.65-1.75],0.7868428036031507
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholelithiasis,23070,1051,1.25 [1.04-1.50],0.0162261699551074
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic gastritis,18389,298,1.23 [0.87-1.74],0.2379579937118892
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22054,35,2.71 [1.55-4.74],0.0004570617354776
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24097,63,3.70 [2.74-5.01],2.28345018859463e-17
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Coeliac disease,22817,127,2.26 [1.58-3.21],6.3918894507400326e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Collagenous colitis,22499,95,1.46 [0.80-2.66],0.217415802324213
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24044,140,0.89 [0.53-1.51],0.6628182885469243
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Constipation,23868,1484,1.10 [0.94-1.29],0.2537053856257953
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn disease,22478,74,2.00 [1.23-3.27],0.0053212675347298
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23849,52,2.27 [1.33-3.90],0.0028516345239299
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22480,76,2.01 [1.24-3.25],0.0044671266809666
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Dental caries,23433,204,1.01 [0.66-1.54],0.9777684951488144
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22728,2154,1.06 [0.92-1.21],0.4232173253603531
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of appendix,24038,160,0.94 [0.57-1.53],0.7936724757654656
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of liver,24083,701,1.81 [1.49-2.20],1.352554367353751e-09
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22145,4054,1.03 [0.93-1.13],0.5660654011573789
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23750,521,1.10 [0.84-1.43],0.4887036283506244
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24057,470,1.30 [0.99-1.69],0.0550150982194091
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23335,106,1.16 [0.66-2.05],0.5991889217550344
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23201,58,1.48 [0.73-3.01],0.2756516983309195
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23910,1220,1.38 [1.17-1.63],0.0001154065650094
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of tongue,23206,90,0.71 [0.36-1.38],0.3112680056832909
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23418,1399,1.32 [1.13-1.54],0.0005462906248177
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20074,2803,0.90 [0.80-1.01],0.0682824705570322
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Duodenal ulcer,18211,120,1.44 [0.85-2.46],0.1744858409714331
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24119,100,1.43 [0.80-2.57],0.225806438912833
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24079,55,1.02 [0.45-2.30],0.9587548240137062
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23463,81,3.46 [2.56-4.68],7.17084746189993e-16
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17374,103,1.03 [0.56-1.88],0.9272227907123024
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Functional dyspepsia,18681,590,1.01 [0.78-1.31],0.930134274154582
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastric ulcer,18396,305,1.02 [0.71-1.46],0.9155695480314402
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20539,2448,0.95 [0.84-1.08],0.454853726607029
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18511,420,1.07 [0.79-1.45],0.6582184746641164
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18907,7398,1.06 [0.99-1.14],0.0908629819272437
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,GI-bleeding,23664,974,1.19 [0.98-1.44],0.0818580020247804
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23290,61,1.70 [0.89-3.23],0.1075493719153265
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18115,1102,0.97 [0.81-1.17],0.7775113880408886
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23416,34,2.18 [1.05-4.50],0.0354751854661124
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Hernia,23114,2540,1.07 [0.95-1.21],0.2640254805592386
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Impacted teeth,24088,51,1.14 [0.50-2.57],0.7588527466996657
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Impaction of intestines,17331,60,1.62 [0.81-3.25],0.1699841926702639
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Inguinal hernia,20723,149,1.53 [0.96-2.45],0.0742575798876998
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,17356,85,0.93 [0.47-1.84],0.8455499255510984
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22843,153,1.90 [1.30-2.76],0.0008268080680957
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17984,713,0.97 [0.77-1.22],0.8091368888847306
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24159,303,1.83 [1.37-2.43],3.266486633719057e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23129,725,1.47 [1.19-1.81],0.0002863077528364
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23372,968,1.39 [1.15-1.67],0.0005562458222747
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18226,135,1.12 [0.66-1.92],0.6682081922980287
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophagitis,18597,506,1.07 [0.82-1.41],0.60999345076487
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24126,142,1.23 [0.75-2.02],0.4159794746499461
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20625,51,0.82 [0.34-2.00],0.660501092094711
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18369,1098,0.96 [0.80-1.16],0.6676192426271781
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22278,259,1.38 [0.96-1.98],0.0808680454688519
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22184,165,0.97 [0.60-1.58],0.9121134173597903
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestine,18652,1381,1.05 [0.89-1.24],0.529584440194494
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestines,22258,4987,1.04 [0.95-1.13],0.4024245419744996
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23204,205,1.19 [0.79-1.81],0.4091884681029198
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of liver,23966,584,1.91 [1.56-2.34],3.4702536147149367e-10
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18616,525,1.19 [0.92-1.56],0.1914189792160718
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22156,137,1.55 [0.95-2.51],0.079797981395023
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23999,412,1.28 [0.96-1.70],0.0928938393350831
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19039,948,1.35 [1.11-1.63],0.0024774229873408
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23681,991,1.21 [1.00-1.46],0.0491028746439342
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23385,156,1.40 [0.90-2.18],0.1330558898544747
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18807,1536,1.12 [0.96-1.31],0.1586399587124036
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19936,1845,1.18 [1.03-1.36],0.018104706245847
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23470,88,2.96 [2.14-4.10],6.197474638844259e-11
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23259,855,1.45 [1.19-1.76],0.000177202490742
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17565,294,1.35 [0.96-1.88],0.0818197829594028
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24069,64,1.03 [0.49-2.20],0.9300348220359196
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17708,437,1.36 [1.03-1.79],0.0294141748981629
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22813,123,2.09 [1.45-3.02],7.962535350040581e-05
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24160,65,2.27 [1.39-3.70],0.001010651912288
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23231,118,1.91 [1.28-2.87],0.0016814010749122
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Toxic colitis,22459,55,2.01 [1.04-3.90],0.0389507471404455
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18303,212,0.99 [0.64-1.52],0.958891744907328
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcerative colitis,22554,150,1.51 [0.97-2.35],0.0685554261123949
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22530,126,1.56 [0.98-2.49],0.0589825994673284
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Umbilical hernia,20729,155,0.94 [0.57-1.56],0.8131334779826169
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17440,169,1.12 [0.70-1.78],0.6425973577848423
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ventral hernia,20793,219,1.54 [1.07-2.21],0.0207805677994854
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Volvulus,17346,75,1.35 [0.70-2.61],0.3771648897111092
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24092,219,1.10 [0.73-1.68],0.6434618233791535
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23883,76,1.11 [0.56-2.21],0.7623560506127898
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22368,198,1.10 [0.71-1.70],0.6603603647331547
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23689,550,1.43 [1.11-1.84],0.0055893409868212
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23271,132,1.55 [0.99-2.45],0.0563999706386189
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22450,280,1.46 [1.02-2.07],0.0359022059017822
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23888,250,1.35 [0.94-1.92],0.1030891477125115
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24066,428,1.61 [1.26-2.07],0.0001760653200001
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23683,45,1.93 [1.02-3.64],0.04380918976282
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22764,2790,1.13 [1.01-1.27],0.0337416508421938
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23774,414,1.04 [0.77-1.40],0.8010013680297562
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23644,284,1.12 [0.79-1.60],0.5212912465640234
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23880,741,1.35 [1.09-1.68],0.0057635554100541
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24149,68,1.23 [0.59-2.57],0.5814158442600108
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22257,87,1.83 [1.11-3.02],0.0174255830739724
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23401,41,1.26 [0.51-3.06],0.6175964576575848
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23874,236,1.35 [0.93-1.95],0.1147418270776379
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22537,367,1.24 [0.91-1.70],0.1741621300555924
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22217,47,0.86 [0.34-2.18],0.7550400514200045
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24076,70,1.01 [0.48-2.12],0.9727549031581294
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23272,133,1.74 [1.07-2.84],0.026557242795918
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23960,153,1.25 [0.78-2.01],0.352831866908226
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23681,43,1.21 [0.47-3.09],0.691634394269536
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22228,58,0.80 [0.35-1.83],0.5910279431175982
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23574,1404,1.14 [0.96-1.34],0.1265315028778046
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22567,397,1.17 [0.86-1.58],0.3240469419376652
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22220,50,0.82 [0.33-2.03],0.6752292030354958
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24093,286,1.16 [0.81-1.65],0.4248998547278136
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23712,74,2.44 [1.64-3.64],1.227542584735442e-05
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24028,221,1.16 [0.78-1.74],0.4581291795968938
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24120,247,1.16 [0.78-1.71],0.4630033461647126
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22314,144,1.17 [0.71-1.93],0.5373657093666439
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22402,232,0.65 [0.42-0.99],0.0438915173106475
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24108,235,1.08 [0.72-1.62],0.7006788204947418
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22346,176,1.97 [1.35-2.89],0.0004531006504513
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24135,129,1.07 [0.63-1.84],0.7983635816587368
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20622,117,0.82 [0.46-1.46],0.502659951401327
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21948,5626,0.97 [0.89-1.06],0.4855564006103852
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20730,4408,0.99 [0.90-1.09],0.915081137713338
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20572,67,0.94 [0.44-2.01],0.8796190058197435
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20743,132,0.45 [0.26-0.79],0.0051308469575237
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20795,184,0.86 [0.54-1.37],0.5186279672975082
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23915,102,1.26 [0.70-2.25],0.4416401884242784
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20714,103,0.75 [0.40-1.42],0.3751961585956161
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17541,1219,0.97 [0.81-1.16],0.7300888754083157
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24030,200,1.12 [0.72-1.73],0.6150601891220759
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21125,514,0.78 [0.59-1.03],0.081431866960246
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20304,7176,0.99 [0.92-1.07],0.764564562348757
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21636,122,0.60 [0.34-1.08],0.0877306054953778
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20626,121,1.27 [0.75-2.16],0.3776903379996448
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21117,612,0.88 [0.68-1.14],0.3252292255556393
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23265,2654,0.87 [0.77-0.98],0.0245875360605941
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20664,159,1.06 [0.65-1.72],0.819683960973121
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20847,342,0.80 [0.57-1.12],0.1979436399861741
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20661,156,1.02 [0.62-1.67],0.9515515858419632
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23296,96,1.18 [0.63-2.21],0.6106254141443876
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17982,1660,0.96 [0.82-1.12],0.6018038721893588
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16504,182,1.54 [0.99-2.41],0.0580141114180414
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24155,179,1.66 [1.07-2.57],0.0223067305243021
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16415,93,0.54 [0.28-1.06],0.0755059678861094
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16837,515,0.73 [0.55-0.98],0.0334619242174815
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20801,296,0.97 [0.68-1.39],0.8677424164086703
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16882,560,0.92 [0.70-1.20],0.5273888100392715
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20670,59,1.50 [0.70-3.22],0.2952907108196475
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21241,630,0.93 [0.72-1.19],0.5426748063138006
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20903,292,0.76 [0.52-1.10],0.1463656327322828
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16841,519,0.86 [0.65-1.13],0.2721573803554031
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20581,76,0.89 [0.43-1.80],0.7364010035166721
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20565,60,1.14 [0.53-2.47],0.7354301845667159
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21557,43,1.41 [0.58-3.43],0.4460846376215774
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23746,2232,1.10 [0.96-1.25],0.1764827574629252
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23122,1608,1.12 [0.96-1.31],0.1414704674496689
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23983,522,1.29 [1.00-1.67],0.0526099117567112
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19017,2695,1.05 [0.93-1.18],0.4673432172786245
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16384,62,0.32 [0.14-0.72],0.0057793746817655
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20596,91,1.23 [0.66-2.29],0.5177173615581254
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16364,42,2.13 [0.92-4.90],0.0758509796053347
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16504,182,0.71 [0.44-1.14],0.1562052022508587
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21777,263,1.06 [0.72-1.55],0.7649639853595829
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22018,504,1.15 [0.88-1.52],0.3134012943246701
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24144,95,1.84 [1.11-3.05],0.0175703407682494
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22400,1789,0.85 [0.73-0.98],0.027884744651403
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20618,113,0.65 [0.36-1.19],0.1623640702637632
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16532,210,0.80 [0.51-1.24],0.3188362053017878
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21323,712,0.79 [0.63-1.00],0.0549532668805299
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18575,2253,0.84 [0.73-0.96],0.0087890045882691
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23316,116,1.39 [0.80-2.41],0.2446744878754522
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24150,75,0.92 [0.45-1.87],0.8208387548288276
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20570,65,1.25 [0.60-2.59],0.5552319866647841
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21806,1301,1.16 [0.98-1.36],0.0879946978289228
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20578,73,1.43 [0.75-2.71],0.2778352645780534
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18082,1760,0.92 [0.79-1.07],0.2959972952035163
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21644,130,0.58 [0.33-1.02],0.0578479488513883
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20555,50,0.80 [0.32-1.96],0.6200135851262889
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20786,175,0.64 [0.39-1.04],0.0716454715838263
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21013,508,1.66 [1.31-2.11],2.646038472880333e-05
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23656,456,1.75 [1.36-2.27],1.9359751686157e-05
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21180,569,1.20 [0.94-1.54],0.1506332000910054
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23995,505,1.34 [1.03-1.73],0.0280086617399143
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24142,58,1.09 [0.49-2.41],0.8381456423254348
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20703,198,0.88 [0.56-1.38],0.5812245334191513
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18535,805,1.03 [0.83-1.28],0.7828670840327604
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21093,588,1.03 [0.80-1.33],0.8285831345423025
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20614,109,1.10 [0.61-1.97],0.7603071187507628
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16395,73,0.91 [0.43-1.92],0.800834910663621
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18656,2334,1.00 [0.88-1.14],0.996825513079793
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17061,739,0.95 [0.75-1.20],0.6544927465554051
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23462,262,0.99 [0.67-1.47],0.9783333560990862
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24119,70,1.82 [1.00-3.31],0.0505210263319108
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22139,48,0.58 [0.23-1.45],0.2409484279824373
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16398,76,0.95 [0.46-1.95],0.8910176347298395
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20710,99,0.92 [0.49-1.72],0.7878667428461833
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16848,526,1.26 [0.97-1.64],0.0823782031301425
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20791,286,0.82 [0.57-1.20],0.3077462950310056
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20864,253,0.81 [0.55-1.21],0.3097314655144332
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20854,243,0.84 [0.56-1.27],0.4138595645910288
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18635,75,1.04 [0.51-2.15],0.908180961376215
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24148,64,1.14 [0.53-2.41],0.7412509162466188
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21066,561,0.91 [0.70-1.18],0.4825774002427681
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23349,149,2.71 [2.09-3.51],4.0717194597573334e-14
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22995,2490,1.06 [0.93-1.19],0.3821071685093086
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20643,138,0.93 [0.55-1.59],0.7955178212401752
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21100,489,0.95 [0.72-1.26],0.7270485189141991
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22618,229,0.86 [0.57-1.31],0.4838057635431333
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20828,217,0.69 [0.44-1.06],0.0920202133446213
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22135,1524,0.84 [0.72-0.99],0.0392464609427485
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21645,1034,0.75 [0.61-0.91],0.0039875332490432
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20561,56,0.98 [0.43-2.26],0.9700636766474888
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23415,215,2.31 [1.82-2.94],6.595356339248786e-12
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20684,179,0.93 [0.58-1.48],0.7509389980385723
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20621,116,1.28 [0.73-2.23],0.3933647482136867
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16367,45,0.36 [0.14-0.96],0.0411998428906468
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23316,1050,2.06 [1.77-2.40],1.245194177791126e-20
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18086,88,0.82 [0.42-1.61],0.5660171949615294
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23557,99,1.03 [0.56-1.90],0.9161618319132364
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24027,203,1.28 [0.85-1.93],0.2352470678685509
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23847,23,0.36 [0.10-1.36],0.1318888765049441
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23437,1171,1.74 [1.47-2.05],5.469073926909871e-11
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24027,58,2.91 [1.67-5.06],0.000153973406209
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23994,203,1.78 [1.23-2.57],0.0021264650361645
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Cystitis,21348,222,1.29 [0.86-1.92],0.2207253692872022
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Dialysis,22312,46,2.45 [1.31-4.58],0.0049992096289197
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23745,287,1.13 [0.79-1.61],0.497370330203293
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Endometriosis,18150,152,1.14 [0.70-1.84],0.6034721022237965
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18342,344,0.74 [0.53-1.04],0.0820735939960655
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18877,879,0.79 [0.64-0.98],0.0302527636160071
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18787,4355,1.11 [1.01-1.22],0.0282026466021034
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24021,52,2.39 [1.42-4.02],0.001014169316267
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22144,182,1.34 [0.87-2.07],0.1900106595065417
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23683,352,1.36 [1.00-1.85],0.0478275925525081
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Irregular menses,23757,111,0.57 [0.32-1.02],0.0584176750827978
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18267,269,0.93 [0.64-1.35],0.7162285403865807
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21193,67,1.53 [0.78-3.02],0.2151835440889815
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,20140,2142,0.85 [0.74-0.97],0.0191891851314407
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18117,119,0.84 [0.47-1.50],0.5565249327939294
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24159,57,0.98 [0.43-2.24],0.9656189282875448
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24159,71,1.06 [0.51-2.19],0.8809965377405177
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23069,1943,1.18 [1.02-1.35],0.0220020684606308
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21538,412,0.95 [0.69-1.29],0.7195354580684592
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23560,102,1.06 [0.58-1.93],0.8565134541699632
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24116,325,1.80 [1.36-2.39],4.706547892460602e-05
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24115,77,0.63 [0.30-1.30],0.2081783980620856
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22791,1665,1.28 [1.11-1.48],0.0009649238828486
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23513,182,1.57 [1.05-2.34],0.0294612766273069
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18135,137,0.83 [0.49-1.43],0.5116257416134439
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18340,342,0.80 [0.57-1.13],0.2037686382633145
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18101,103,0.80 [0.43-1.49],0.4801278488854659
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18180,182,0.64 [0.40-1.03],0.0674900597149733
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22190,228,1.36 [0.92-2.00],0.1226229190164974
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23899,108,1.69 [1.03-2.78],0.039316634875495
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18266,268,1.13 [0.78-1.64],0.5222975217597314
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18089,91,0.77 [0.40-1.49],0.4382585231006641
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18561,563,0.79 [0.61-1.03],0.0842701052217086
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,18139,141,0.88 [0.51-1.50],0.6400187434481257
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18512,514,0.77 [0.58-1.02],0.0647819340071794
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24002,33,1.44 [0.55-3.79],0.4564903379730243
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24014,2052,1.76 [1.56-1.99],2.990426285531697e-20
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22109,147,2.29 [1.71-3.07],2.9145317747473203e-08
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22349,83,2.36 [1.50-3.72],0.0002255316900825
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23855,31,1.05 [0.35-3.09],0.936208605775522
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21255,129,1.28 [0.76-2.14],0.3549293390363249
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24057,233,1.13 [0.76-1.67],0.5475350510789778
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18117,119,0.83 [0.47-1.47],0.5228718317098697
